Introduction {#Sec1}
============

Chemorepellents are molecules that inhibit or repel the migration of individual cells. In protozoans, chemorepellents are hypothesized to serve a defense mechanism, helping the organism to avoid predation and environmental hazards. For example, a damaged *Tetrahymena thermophila* cell may leak cytosolic purines such as adenosine triphosphate (ATP) or guanosine 5\'-triphosphate (GTP) into the surrounding environment, causing other cells to avoid the area, thereby avoiding the source of damage to the original cell and increasing the survival rate of the species \[[@CR1], [@CR2]\]. It is possible that cytosolic purines may be secreted by these organisms as a means of communication between cells (analogous to paracrine secretion) or in order to trigger second-messenger pathways within the cell doing the secretion (analogous to autocrine secretion). At this time, secretion of purine nucleotide by *Tetrahymena* has not been documented, although *Tetrahymena* have been shown to secrete a number of enzymes and peptides.

In *T. thermophila*, extracellular GTP is a known chemorepellent \[[@CR1], [@CR3], [@CR4]\]. GTP causes depolarization in the somatic membrane \[[@CR2]\], which has been proposed to trigger opening of the voltage-dependent calcium channels in the ciliary membrane \[[@CR2]\]. The increase in Ca^2+^ concentration causes the cilia to reverse their direction \[[@CR1]\], resulting in a disruption of normal swimming. This "avoidance reaction" \[[@CR1]\] is marked by jerky movements, backward swimming, or spinning. This chemokinetic response involves a series of avoidance reactions, resulting in a "biased random walk," which orients the organism away from the source of the repellent \[[@CR3]\]. Avoidance to chemorepellents may be quantified by observing the response of single cells exposed to repellent using a dissection microscope.

*T. thermophila* avoid micromolar concentrations of GTP \[[@CR1]\]. An *in vivo* binding assay using \[32P\] GTP showed the K~D~ for GTP binding to intact *T. thermophila* is 21 ± 2.5 nM. GTP binds to its receptor with high affinity, and binding is saturable as well as reversible \[[@CR1]\], all of which are characteristic of membrane receptors. Fluorescent staining with 2′-(or 3′)-*O*-(2,4,6-trinitrophenyl) (TNP)-GTP has shown GTP binding on the cilia and cell surface of *T. thermophila* \[[@CR4]\]. However, the second messenger pathways involved in GTP signaling have not been previously described.

Recently, Iwamoto and Nakaoka \[[@CR4]\] found that addition of extracellular GTP to the medium induces cell division in *T. thermophila*, a result consistent with a tyrosine kinase signaling mechanism, as tyrosine kinases are involved in many major mitotic pathways. Tyrosine phosphorylation has previously been shown to modulate the interaction of calmodulin with target proteins, including protein phosphatase 2B (calcineurin) and neuronal nitric oxide synthase (nNOS) in an in vitro assay \[[@CR5]\]. Tyrosine kinase activity has also been shown to activate phospholipase C, NOS (via protein kinase C), and guanylyl cyclase in the rat ileum \[[@CR6]\]. Tyrosine kinases are frequently associated with activation of phospholipase C-γ, and with release of calcium from internal stores via the IP~3~ pathway \[[@CR7]\].

In our current study, we examined the hypothesis that GTP signals through a tyrosine kinase pathway in *T. thermophila*. Our data confirm this hypothesis. In addition to tyrosine kinase signaling, we found that phospholipase C, intracellular calcium stores, NOS, and guanylyl cyclase are necessary for behavioral avoidance to occur. All of these second messengers are consistent with the existence of a tyrosine kinase signaling pathway in *T. thermophila*.

Materials and methods {#Sec2}
=====================

Cell cultures {#Sec3}
-------------

*T. thermophila*, strain B2086, a generous gift from T.M. Hennessey (SUNY-Buffalo) were used for all of the experiments. Cells were grown at 25°C in the axenic medium of Dentler \[[@CR8]\] without shaking. Two-day-old cell cultures were used for all assays described below.

Chemicals and solutions {#Sec4}
-----------------------

Behavioral assays were carried out in a buffer of pH 7.0 containing 10 mM Trizma base, 0.5 mM MOPS, and 50 μM CaCl~2~. All repellents and inhibitors used were dissolved in this buffer. Compounds that were insoluble in aqueous solutions were first dissolved in a small quantity of dimethylsulfoxide (DMSO) and then diluted 1:1,000 or more into the buffer and vortexed vigorously. The chemorepellent guanosine-5′-O-(3-thio)triphosphate (GTP-γ-S) was obtained from Alexis Biochemicals (San Diego, CA, USA), along with the G-protein inhibitor pertussis toxin. The tyrosine kinase inhibitor genistein was obtained from Acros Organics (New Jersey, USA). Calphostin C \[a protein kinase C (PKC) inhibitor\], diadzein a control for genistein inhibition), guanosine-5′-O- (2-thiodiphosphate) (GDP-β-S) (a G-protein inhibitor), Rp-8-Bromoguanosine-3′,5′-cyclic monophosphorothioate (Rp-8-Br-cGMPs) (a competitive inhibitor of PKG), 1-(6-(17β-3-methoxyestra-1,3,5(10)-trien-17-yl) amino)hexyl)-1H-pyrrole-2,5-dione (U73122) (a phospholipase C inhibitor), NG-monomethyl-L-arginine (L-NMMA), and N-(3-(Aminomethyl)benzyl)acetamidine (1400W) (NOS inhibitors), 4H-8-bromo-1,2,4-oxadiazolo(3,4-d) benz(b)(1,4)oxazin-1-one (NS2028) (a PKG inhibitor), and the Quantizyme nitric oxide (NO) assay kit were purchased from BIOMOL Research Laboratories (Plymouth Meeting, PA, USA). The polyclonal antiphosphotyrosine antibody was purchased from Upstate (Lake Placid, NY, USA); 30X Tris-buffered saline (TBS) and 30X TBS/nonidet P40 (NP40) were obtained from Modern Biology (West Lafayette, IN, USA). The guanosine 3′3;5′monophosphate (cGMP) emzyme immunosorbent assay (EIA) kit was purchased from Cayman Chemical (Ann Arbor, MI, USA). Sodium metavanadate (a phosphatase inhibitor) and theophylline (a phosphodiesterase inhibitor) were obtained from Sigma Chemical (St. Louis, MO, USA). All other chemicals were purchased from Sigma as well.

Behavioral assays {#Sec5}
-----------------

In vivo behavioral assays were carried out as previously described \[[@CR1], [@CR9], [@CR10]\]. Briefly, cells were washed in buffer, and 300 μl of cell suspension was transferred to the first well of a three-well spot microtiter plate. Cells were then individually transferred by micropipette to the second well, which contained 300 μl of the test concentration of inhibitor dissolved in buffer. After at least 10--15 min of incubation time, individual cells were transferred to the third well, which contained 300 μl GTP-γ-S and the test concentration of inhibitor. Each cell was briefly observed (1--5 s) for signs of avoidance. Avoidance behavior was characterized by jerky, backward movements; swimming in small, tight circles; sudden reversal of swimming direction; or any deviation from the normal helical swimming pattern of *T. thermophila*.

Western blots {#Sec6}
-------------

Western blots were performed as follows: For each sample, 10 ml of the same 2-day-old culture was washed 3× in behavioral buffer; 100 μM GTP-γ-S (the concentration required to elicit 100% avoidance) was added to the tube of cells marked GTP. The control tube received only buffer; no GTP was added. Both tubes were immediately extracted with 0.1% sodium dodecyl sulphate (SDS) in the presence of 1 mM sodium orthovanadate for 30 min at 4°C. Extracts were spun at 16,000 g at 4°C for 30 min to precipitate insoluble components. Supernatant was collected, and 5× loading buffer was applied in preparation for SDS polyacrylamide gel electrophoresis (PAGE); 100 μl of each sample was applied to a 10% SDS-PAGE. Amount of protein loaded onto the gel was standardized using the BIO-RAD protein assay; in addition, a control, Coomassie-stained gel, was run to show that equal amounts of protein were loaded into each well. Proteins were transferred from the SDS-PAGE to nitrocellulose for 30 min at 150 mA. Blots were then blocked overnight in a 3% solution of powdered milk. Blots were incubated with a 1:1,000 dilution of polyclonal phosphotyrosine antibody in the presence of 3% powdered milk for 1.5 h, washed 3× in TBS, then incubated with a 1:100 dilution of alkaline phosphate conjugated anti-rabbit antibody for 1.5 h in the presence of 3% powdered milk. Blots were then washed 3× with TBS and incubated for 5 min in an alkaline phosphatase buffer containing 100 mM NaCl, 5 mM MgCl~2~, 100 mM Trizma base, pH 9.5 with hydrogen chloride (HCl). Alkaline phosphatase buffer was then removed, and blots were developed using the Sigma-Fast system until bands were visible.

EIA assays {#Sec7}
----------

NO assays were carried out using 2-day-old cell cultures. Cells were washed twice in buffer and diluted to a final concentration of approximately 720 cells/ml. Cells were exposed to 100 μM GTP-γ-S for approximately 30 s, then spun down in a bench-top microcentrifuge for 30 s. Control cells were spun under identical conditions except that no GTP was added to the solution. Supernatant from both sets of cells was analyzed for NO using a kit from BIOMOL according to the manufacturer's instructions.

cGMP assays were carried out using 2-day-old cell cultures. Cells were concentrated to approximately 7.66 × 10^6^ cells/ml in order to maximize cGMP production. Cells were exposed to 100 μM GTP for approximately 30 s, then immediately lysed by freezing in liquid nitrogen and thawing. Theophylline (1 mM) was added to the lysate to inhibit phosphodiesterases. Lysate was spun at 16,000 g for 30 min. Control cells were treated in identical fashion except for the addition of GTP. Supernatant from both sets of cells was assayed for cGMP using a kit from Cayman Chemicals according to the manufacturer's instructions.

Immunofluorescence {#Sec8}
------------------

Ten milliliters of 2-day-old cells were starved overnight in behavioral buffer then washed 3× in behavioral buffer and concentrated down into 2 ml. Mucocysts were removed by adding Alcian Blue GX to a final concentration of 0.05%, then adding nine volumes of 0.25% proteose peptone \[[@CR11]\]. Mucocysts were allowed to precipitate by standing the tube in a rack for 10 min. Supernatant (including cells) was removed from the top of the tube. The cells were then washed 3× in behavioral buffer to remove any remaining mucocysts or Alcian Blue and concentrated down into 3 ml total; 1 ml of cells was set aside as the control cells. Another milliliter of cells was incubated with 100 μM GTP-γ-S. A third aliquot was incubated with 100 μg/ml genistein prior to GTP treatment. Immediately, all three aliquots of cells were fixed in 3.7% formaldehyde (from 37% stock diluted into behavioral buffer) with gentle shaking for 20 min. Cells were washed 3× in 1× TBS/NP40 (Modern Biology) then incubated with a 1:100 dilution of polyclonal antibody in 1× TBS/NP40 for 1.5 h. Cells were again washed 3× in 1× TBS/NP40 then incubated in a 1:100 dilution of fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG (ICN Biomedicals) for 1.5 h. Cells were washed 3× in 1× TBS before being viewed under a Nikon microscope at 400×. Cells were photographed using a SPOT digital camera using a 10-s exposure for each photograph.

Results {#Sec9}
=======

GTP-γ-S is a chemorepellent in *Tetrahymena,*, with a minimum concentration of 100 μM required for 100% avoidance (Fig. [1](#Fig1){ref-type="fig"}). This concentration was used in the inhibition studies that follow as well as in our biochemical studies. We used GTP-γ-S in our experiments rather than GTP to minimize the effects of the ecto-ATPase upon the assays \[[@CR3]\]. However, the activity of apyrases and other ectoenzymes may still have degraded some of the GTP-γ-S before it could reach its intended receptor. The concentration of GTP-γ-S required in order to achieve 100% avoidance in this study was 5× higher than that previously published \[[@CR1]\]; however, considering that the cell line and growth conditions were different than those published earlier, this finding is not unexpected. The EC~50~ of GTP-γ-S in this study was approximately 30 μM. Fig. 1Guanosine-5′-O-(3-thio)triphosphate (GTP-γ-S) is an effective chemorepellent in *Tetrahymena*. In vivo behavioral bioassays (see "Materials and methods") were used to show the concentration dependencies for avoidance reactions to GTP-γ-S. The percentage of cells showing avoidance was determined by observation of a single cell after transfer to the test solution. Each trial consisted of ten cells, which were individually scored as to whether or not avoidance occurred. Each point represents the mean ± standard deviation (SD) of at least three trials.*Error bars*, representing the standard deviation, are shown for each point. Minimum concentration required to give 100% avoidance was 100 μM for GTP-γ-S. This concentration was used in the inhibition studies that follow. The EC~50~ of this compound was approximately 30 μM

To determine whether a tyrosine kinase activity was involved in GTP avoidance, we used the tyrosine kinase inhibitor, genistein (Fig. [2](#Fig2){ref-type="fig"}). Genistein itself did not cause avoidance reactions, nor was it toxic to the cells. Baseline avoidance of ∼ 20% \[[@CR9]\] to 100 μM GTP-γ-S was seen at a genistein concentration of 100 μg/ml. The inhibition constant (IC)~50~ of genistein was approximately 40 μg/ml. Another phytoestrogen, daidzein, served as a control for nonspecific side effects of genistein. As seen in Fig. [2](#Fig2){ref-type="fig"}, this compound had no measurable effect on avoidance at the tested concentrations, suggesting that the inhibitory effect of genistein was indeed due to its tyrosine kinase inhibition and not attributable to some side effect of the drug. Fig. 2The tyrosine kinase inhibitor, genistein, blocks avoidance to 100 μM guanosine-5′-O-(3-thio)triphosphate (GTP-γ-S) in *Tetrahymena*. The phytoestrogens genistein (*closed circles*) and daidzein (*open circles*) were used as inhibitors of avoidance. Baseline avoidance was seen at a genistein concentration of 100 μg/ml. The IC~50~ of genistein was approximately 40 μg/ml. Daidzein served as a control for nonspecific effects of genistein and had no measurable effect on avoidance at the concentrations tested. Data shown represent the mean +/− standard deviation (SD) for three or more trials

As an additional control for specificity, we tested whether genistein had any effect on the transduction of another chemorepellent, adenosine 5′-O-(3-thio)triphosphate (ATP-γ-S). We used 150 μM ATP-γ-S, a concentration that normally causes 100% avoidance in *T. thermophila* \[[@CR12]\]. When cells exposed to ATP-γ-S were first incubated for 10--15 min in 100 μg/ml genistein, no measurable effect on avoidance was seen. Cells continued to avoid 150 μM ATP-γ-S at a rate of 96.6 + 5.8% (*n* ≥ 3). Genistein also failed to affect avoidance to the chemorepellent pituitary adenylate cyclase-activating polypeptide (PACAP). When testing 0.1 μM PACAP, which normally causes 100% avoidance in *T. thermophila* \[[@CR9]\], we found that prior incubation with 100 μg/ml genistein did not markedly affect avoidance. Cells continued to avoid 0.1 μM PACAP at a rate of 96.6 + 5.8% (*n*≥ 3). These data suggest that tyrosine kinase activation is specifically related to GTP exposure rather than being a general response to chemorepellent exposure.

In an attempt to localize the phosphotyrosines within the cell, immunofluorescence experiments were performed using a polyclonal antiphosphotyrosine antibody. Three separate trials were done with this antibody, and representative photographs are compiled in Fig. [3](#Fig3){ref-type="fig"}a--c. GTP-exposed cells (Fig. [3](#Fig3){ref-type="fig"}b) showed higher overall fluorescence intensity than did the controls and genistein-treated GTP-exposed cells (Fig. [3](#Fig3){ref-type="fig"}a,c). Ciliary staining was seen in the GTP-exposed cells, along with punctuate staining of the cytosol. The control and genistein-treated GTP-exposed cells showed the same cytosolic staining pattern, but ciliary staining was not detected in these control groups, perhaps because the overall fluorescence level of these cells was so low. Fig. 3Guanosine 5\'-triphosphate (GTP) exposure increases tyrosine kinase activity in *Tetrahymena.***a--c** Immunofluorescence labeling of phosphotyrosines in *Tetrahymena* is evidence of tyrosine kinase activity. Control (**a**), GTP-exposed (**b**), and genistein-treated GTP-exposed cells (**c**) were fixed and labeled with a polyclonal antiphosphotyrosine antibody. GTP-exposed cells showed higher fluorescence intensity than did control cells and cells treated with the tyrosine kinase inhibitor genistein. In addition, GTP-exposed cells showed ciliary staining in addition to punctuate staining of the cytosol. Total magnification 400×. Cell length ∼ 50 μm.**d** Western blot of whole-cell extract obtained from control and GTP-exposed cells using a polyclonal antiphosphotyrosine antibody shows increased phosphorylation levels in extract taken from GTP-exposed cells (*lane 2*) relative to extract from control cells (*lane 3*). A 66-kDa phosphoprotein stained similarly in both the GTP and control lanes, whereas bands of 42, 35, and 21 kDa were more heavily stained in the GTP lane relative to the control lane. Molecular weight markers are shown in the*first lane* (molecular weights in kDa). A Coomassie-stained sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) run as a loading control showed equivalent staining of proteins in all lanes (not shown)

To determine which proteins were being phosphorylated by the tyrosine kinase in response to GTP-γ-S, we also performed several Western blots of whole-cell extract obtained from control and GTP-γ-S -treated cells using the polyclonal antiphosphotyrosine antibody as a probe. Protein extracts were standardized so that lanes were loaded equally, and a control, Coomassie-stained gel, was also run to control for lane-loading artifacts (data not shown). A representative Western blot is pictured in Fig. [3](#Fig3){ref-type="fig"}d. Both GTP-treated and control cells showed similar staining at 66 kDa. However, increased phosphotyrosine levels were seen in the GTP-γ-S-treated cells at 42, 35, and 21 kDa, consistent with tyrosine kinase activity. These bands were also present in the control cell extract; however, the phosphorylation level in these lanes was so low that they were barely detectable with our staining procedure. Additional bands were also seen in both the GTP-exposed and the control lanes; however, they were also too light to be measurable. A more sensitive assay, such as chemiluminescence based Western blot detection, might help to give a more complete profile of the phosphotyrosine-containing proteins shown in this procedure.

In many cells, activation of a tyrosine kinase activates phospholipase C-γ. We used the phospholipase C inhibitor, U73122, to determine whether phospholipase C might be involved in GTP avoidance. GTP avoidance was effectively eliminated at a U73122 concentration of 1 μM. This concentration was ten times lower than that used to inhibit phospholipase C in molluscan ciliary cells \[[@CR12]\]. The IC~50~ of this compound was approximately 0.001 μM. Phospholipase C activates the PKC pathway through the generation of diacylglycerol (DAG) and inositol 1,4,5 trisphosphate (IP~3~). PKC is then activated by DAG binding in the presence of calcium. To determine whether PKC was involved in GTP avoidance, we used the PKC inhibitor calphostin C, which competes for DAG binding to PKC. In the presence of 10 μM calphostin C, avoidance to 100 μM GTP-γ-S was reduced only to 96.6 +/− 5.8%, compared with 100% avoidance in control cells. This concentration of calphostin C eliminated avoidance to 150 μM ATP-γ-S \[[@CR13]\]. Because calphostin C had no measurable effect on GTP avoidance, we concluded that PKC activy is not required for GTP signaling. It is very likely that the two second messengers, IP~3~ and DAG, are generated by phospholipase C and that PKC is activated, but that PKC targets cellular substrates that are not directly involved in ciliary reversal.

Because calcium signaling is often associated with tyrosine kinase pathways and because calcium influx is associated with GTP exposure \[[@CR2]\], we decided to eliminate calcium rom cells using the membrane-permeable calcium chelator 1,2-bis-(o-Aminophenoxy)-ethane-N,N,N\',N\'-tetraacetic acid, tetra (acetoxymethyl) ester (BAPTA-AM). As seen in Fig. [5](#Fig5){ref-type="fig"}a, exposure to this calcium chelator eliminated avoidance in a concentration-dependent manner, with baseline avoidance seen at a BAPTA-AM concentration of 5 μg/ml. This result was certainly not surprising, as all known chemorepellents that have been studied electrophysiologically in *Tetrahymena* have elicited depolarizations \[[@CR2], [@CR14], [@CR15]\] that have been proposed to be linked to calcium. Because our data indicated that phospholipase C was involved in GTP avoidance, we decided to test the hypothesis that internal calcium stores may also contribute to avoidance, consistent with the liberation of IP~3~ from the plasma membrane. We used an inhibitor of the endoplasmic reticulum (ER) calcium ATPase, thapsigargin, to deplete ER calcium stores to determine whether these stores were necessary for avoidance. Baseline avoidance to GTP was seen at a thapsigargin concentration of 1,000 nM (Fig. [5](#Fig5){ref-type="fig"}b). The IC~50~ of thapsigargin was approximately 1 nM.

NO is another second messenger sometimes associated with tyrosine kinases \[[@CR5], [@CR17]\] and often associated with calcium signaling \[[@CR5], [@CR18]\]. In addition, NO has been found to be a critical second messenger in the *Tetrahymena* response to both ATP \[[@CR13]\] and PACAP-38 \[[@CR18]\]. To determine whether NO was involved in GTP signaling, we used the NOS inhibitors 1400W (Fig. [6](#Fig6){ref-type="fig"}a) and L-NMMA (Fig. [6](#Fig6){ref-type="fig"}b). Both inhibitors blocked avoidance to 100 μM GTP-γ-S in *Tetrahymena*, with baseline avoidance being reached at 100 nM for 1400W (Fig. [6](#Fig6){ref-type="fig"}a) and 50 μM for L-NMMA (Fig. [6](#Fig6){ref-type="fig"}b). The IC~50~ of 1400W was near 0.1 nM, whereas L-NMMA was approximately 3 μM.

To confirm the activity of NOS in GTP avoidance, we used the Quantizyme NO assay to determine whether there was a difference in NO metabolism between control and GTP-stimulated cells. Cells stimulated with 8 mg/ml GTP had a 146 +/− 4.7% increase in NO levels over control cells, consistent with the inhibitor studies (*n* = 3).

In many cells, NO activates guanylyl cyclase, which then produces cGMP. Previous studies by Christensen et al. \[[@CR20]\] described an NO-linked, possibly soluble guanylyl cyclase activity in *T. thermophila*. More recent studies, reviewed by Linder and Schultz \[[@CR20]\], described a membrane-associated and calcium-dependent guanylyl cyclase in these organisms. To determine whether any guanylyl cyclase isoform was involved in GTP avoidance, we used NS2028, an inhibitor of guanylyl cyclase (Fig. [7](#Fig7){ref-type="fig"}a), as well as Rp-8-bromo-cGMPs, a competitive inhibitor of cGMP (Fig. [7](#Fig7){ref-type="fig"}b), in behavioral assays. NS2028 and Rp-8-bromo-cGMPs both blocked avoidance to 100 μM GTP-γ-S in *Tetrahymena*. Baseline avoidance was obtained at 10 nM NS2028 (Fig. [7](#Fig7){ref-type="fig"}a) and at 50 μM Rp-8-bromo-cGMPs (Fig. [7](#Fig7){ref-type="fig"}b). The IC~50~ of NS2028 was approximately 0.05 nM and of Rp-8-bromo-cGMPs near 7 μM. To confirm these results biochemically, we performed an EIA assay to determine whether GTP exposure resulted in elevated cGMP levels within *Tetrahymena*. Exposure to 5 mg/ml GTP resulted in a 1,119 +/− 4.2% increase above control cGMP levels (*n* ≥ 3), consistent with the hypothesis that GTP avoidance is linked to a guanylyl cyclase.

Based on the data we collected, we put together a provisional model of GTP signaling (Fig. [8](#Fig8){ref-type="fig"}). In our model, GTP binds to a receptor, which activates tyrosine kinase while interacting with a membrane calcium channel, causing a depolarization. Phospholipase C is activated, generating IP~3~, which allows calcium efflux from ER stores. The high cytosolic calcium interacts with some (unknown) isoform of NOS, guanylyl cyclase, and other calcium-binding proteins, ultimately resulting in ciliary reversal. Whereas some of the relationships between second messengers are still unknown, the model has been put together to stimulate thought and discussion and to make some order out of a complex pathway.

Discussion {#Sec10}
==========

The data we have compiled here are consistent with the hypothesis that the previously described GTP receptor \[[@CR1]\] signals through a tyrosine kinase (Fig. [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}). The GTP signaling pathway also involves phospholipase C (Fig. [4](#Fig4){ref-type="fig"}), intracellular calcium (Fig. [5](#Fig5){ref-type="fig"}), NOS (Fig. [6](#Fig6){ref-type="fig"}), and guanylyl cyclase (Fig. [7](#Fig7){ref-type="fig"}). The proposed GTP signaling pathway is outlined in Fig. [8](#Fig8){ref-type="fig"}. Fig. 4The phospholipase C inhibitor 1-(6-(17β-3-methoxyestra-1,3,5(10)-trien-17-yl) amino)hexyl)-1H-pyrrole-2,5-dione (U73122) blocks avoidance to 100 μM guanosine-5′-O-(3-thio)triphosphate (GTP-γ-S) in *Tetrahymena.* Baseline avoidance was reached at a U73122 concentration of 1 μM. The inhibition constant IC~50~ of this compound was near 0.001 μM. Data shown is mean +/− standard deviation (SD) of three or more trialsFig. 5Intracellular calcium is required for guanosine 5\'-triphosphate (GTP) avoidance in*Tetrahymena*. **a** The membrane-permeable calcium chelator 1,2-bis-(o-Aminophenoxy)-ethane-N,N,N\',N\'-tetraacetic acid, tetra (acetoxymethyl) ester (BAPTA-AM) blocks avoidance to 100 μM GTP-γ-S in *Tetrahymena.* Baseline avoidance was reached at a BAPTA-AM concentration of 5 μg/μl. The inhibition constant IC~50~ of this compound was near 0.5 μg/μl. Data shown is mean +/− standard deviation (SD) of three trials. **b** The endothelial reticulum (ER) calcium adenosine triphosphatase (ATPase) inhibitor thapsigargin also blocks avoidance to 100 μM guanosine-5′-O-(3-thio)triphosphate (GTP-γ-S) in *Tetrahymena.*. Baseline avoidance was reached at a thapsigargin concentration of 1,000 nM. The IC~50~ of this compound was near 1 nM. Data shown is mean +/− standard deviation (SD) of three or more trialsFig. 6Nitric oxide synthase (NOS) activity is required for guanosine 5\'-triphosphate (GTP) avoidance in *Tetrahymena*. **a** The NOS inhibitor 1400W blocks avoidance to 100 μM guanosine-5′-O-(3-thio)triphosphate (GTP-γ-S) in *Tetrahymena.* Baseline avoidance was reached at a 1400W concentration of 100 nM. The inhibition constant IC~50~ of this compound was near 0.1 nM. Data shown is mean +/− standard deviation (SD) of three trials. **b** The NOS inhibitor NG-monomethyl-L-arginine (L-NMMA) also blocks avoidance to 100 μM GTP-γ-S in *Tetrahymena*. Baseline avoidance was reached at an L-NMMA concentration of 10 μM. The inhibition constant IC~50~ of this compound was near 3 μM. Data shown is mean +/− standard deviation (SD) of at least three trialsFig. 7Guanylyl cyclase activity is required for guanosine 5\'-triphosphate (GTP) avoidance in *Tetrahymena*. **a** 4H-8-bromo-1,2,4-oxadiazolo(3,4-d) benz(b)(1,4)oxazin-1-one (NS2028), an inhibitor of guanylyl cyclase, blocked avoidance to 100 μM guanosine-5′-O-(3-thio)triphosphate (GTP-γ-S) in *Tetrahymena*. Baseline avoidance was obtained at 10 nM. The inhibition constant IC~50~ of NS2028 was approximately 0.05 nM. Data shown is mean + standard deviation (SD) of three trials. **b** Rp-8-Bromoguanosine-3′,5′-cyclic monophosphorothioate (Rp-8-Br-cGMPs), a competitive inhibitor of guanosine 3′3;5′monophosphate (cGMP), also blocked avoidance to 100 μM GTP-γ-S in *Tetrahymena*. Baseline avoidance was obtained at 50 μM. The IC~50~ of Rp-8-Br-cGMPs was approximately 7 μM. Data shown is mean + standard deviation (SD) of three or more trialsFig. 8Current model of guanosine 5\'-triphosphate (GTP) signaling. Based on data obtained in this experiment, GTP appears to signal through a receptor linked to a tyrosine kinase. Phospholipase C, intracellular calcium release, nitric oxide (NO) production, and guanylyl cyclase are all involved in GTP avoidance. Some of the relationships between pathway components remain unknown. This model is based on the data presented in this paper, along with data obtained from the literature \[[@CR26], [@CR32], [@CR33]\]

GTP is the first chemorepellent we have studied that does not signal through a G-protein-linked receptor, unlike ATP \[[@CR13]\] and PACAP \[[@CR18], [@CR21]\]. In contrast to other repellents, GTP signaling is unaffected by either GDP-β-S or pertussis toxin (unpublished data). GTP is also the only one of these three repellents whose signaling is eliminated by genistein (Fig. [2](#Fig2){ref-type="fig"}; see "Results"). Previously published cross-adaptation data \[[@CR2]\] indicated that GTP and ATP signal through different receptors. These data are consistent with the previously published literature and add the observation that both receptors and second-messenger pathways for these two repellents appear to be different.

Multiple target proteins are phosphorylated in response to GTP exposure (Fig. [3](#Fig3){ref-type="fig"}d), yet the proteins remain unidentified except for molecular weight. Phosphotyrosine immunolocalization does not help us identify these proteins; however, the ciliary staining (Fig. [3](#Fig3){ref-type="fig"}b) opens up the possibility of direct interaction between tyrosine kinase activity and ciliary reversal. This is worthy of note, as Christensen et al. \[[@CR22]\] report a similar increase in ciliary phosphotyrosine labeling after exposure to the chemoattractant insulin. However, in their report, the main protein that was phosphorylated was a 66 kDa protein, which they discovered was homologous to the insulin receptor. In the case of GTP exposure, we saw no increase in labeling of the 66 kDa protein (Fig. [3](#Fig3){ref-type="fig"}d). Taken together, these data raise the possibility that there are multiple tyrosine kinase pathways that act on cilia to increase forward swim speed in the case of a chemoattractant, or to cause ciliary reversal in the case of a chemorepellent. Becausxe there were multiple phosphotyrosine bands in our Western blot (Fig. [3](#Fig3){ref-type="fig"}d) and ciliary as well as cytosolic staining in our immunofluorescence (Fig. [3](#Fig3){ref-type="fig"}b), we see that GTP exposure has both ciliary and cytosolic effects. Ciliary reversal is seen immediately upon GTP exposure; however, other effects of GTP exposure, such as mitosis, are seen hours after GTP exposure \[[@CR4]\]. Perhaps the cytosolic target proteins are involved in other, longer-term effects of GTP, such as mitosis.

Many tyrosine kinase pathways involve phospholipase C. In various *Tetrahymena* species, evidence for phospholipase C involvement has been seen in stomatin-induced differentiation \[[@CR24]\] and in commitment to cell survival or death \[[@CR25]\]. Studies by Leondaritis and Galanopoulou \[[@CR26]\] suggest that *Tetrahymena* possess a functional phosphatidylinositol signaling system that is similar to higher eukaryotes. Indeed, in our previous studies of PACAP \[[@CR10]\] and ATP \[[@CR13]\], phospholipase C involvement is also implicated. In our current study, we found that U73122 effectively eliminated GTP avoidance (Fig. [4](#Fig4){ref-type="fig"}), indicating that phospholipase C signaling is involved in behavioral avoidance. However, our calphostin C data (see "Results") indicate that PKC, a common downstream target of phospholipase C, is not required for GTP avoidance. IP~3~, a second messenger generated by phospholipase C, is likely involved in GTP signaling. Although we could not test IP~3~ involvement directly using our behavioral assay, the fact that the ER calcium ATPase inhibitor thapsigargin eliminated GTP avoidance (Fig. [5](#Fig5){ref-type="fig"}b) is indirect evidence that IP~3~ may be binding to the ER and causing release of calcium from internal stores.

Calcium is a ubiquitous signaling molecule and has been implicated in ciliary reversal in *Tetrahymena*. It was no surprise, then, that BAPTA-AM eliminated GTP avoidance (Fig. [5](#Fig5){ref-type="fig"}a), as it has previously been shown to eliminate avoidance to PACAP \[[@CR18]\] and ATP \[[@CR13]\]. Calcium is likely to play multiple roles in signaling. One possible scenario is the direct interaction of calcium with ciliary motor proteins. For example, inner arm dynein 1 (I1) is required for calcium-dependent ciliary reversals in *T. thermophila* \[[@CR27]\]. In this study, a "calcium sensor," which interacts with I1, was postulated. This calcium sensor protein remains to be isolated.

Intracellular calcium may also play other, less direct, roles in GTP avoidance. Indeed, in the protozoan parasite *Leishmania donovani,* both NOS and guanylyl cyclase are activated by intracellular calcium \[[@CR28]\]. Both NOS (Fig. [6](#Fig6){ref-type="fig"}) and guanylyl cyclase (Fig. [7](#Fig7){ref-type="fig"}) activity are required for GTP avoidance. Previous studies that implicate NOS and guanylyl cyclase in *Tetrahymena* \[[@CR13], [@CR18], [@CR19]\] do not indicate the type of NOS or guanylyl cyclases involved, though Christensen et al. \[[@CR19]\] give evidence for a soluble guanylyl cyclase. In *L. donovani*, there is evidence for a constitutive, neuronal-type NOS that then activates a soluble guanylyl cyclase \[[@CR28]\]. Both of these enzymes are activated by intracellular calcium. Our data would be consistent with a similar mechanism in *Tetrahymena*, as proposed in our model of GTP signaling (Fig. [8](#Fig8){ref-type="fig"}). However, neither a soluble guanylyl cyclase nor an nNOS isoform have been purified from *Tetrahymena* to date.

Calcium-binding proteins, such as calmodulin, may also be involved in GTP signaling in *Tetrahymena*, either by interacting with enzymes that generate second messengers or by interacting with the molecular motors responsible for ciliary reversal. Previous studies \[[@CR29], [@CR30]\] indicate that calmodulin activates a ciliary guanylyl cyclase in this organism. Our studies leave open the possibility that this cyclase, activated by calcium/calmodulin, is involved in GTP signaling. In addition to this enzyme, Hirano-Ohnishi and Watanabe \[[@CR31]\] reported a calmodulin-dependent phosphorylation of ciliary beta tubulin in *Tetrahymena*, which they believe to be involved in ciliary reversal. Elongation factor 1α, which functions in protein translation, also interacts with ciliary calmodulin \[[@CR32]\]. Whereas this would not necessarily function in ciliary reversal, it may modulate some of the longer-term effects of GTP. Finally, Ueno et al. \[[@CR33]\] report that ciliary calmodulin interacts with proteins that are homologues of radial spoke proteins in *Chlamydomonas*, further implicating calmodulin directly in ciliary reversal. We have added some of these proteins to our model of GTP signaling (Fig. [8](#Fig8){ref-type="fig"}), though there are doubtless more proteins to be discovered.

In this study, we used behavioral assays and pharmacological inhibitors to explore the intracellular mechanisms employed in GTP signaling in *T. thermophila*. Because pharmacological inhibitors often have unknown side effects, we used multiple inhibitors when available. Some of these inhibitors had to be used at higher concentrations in our study than have been previously published for mammalian cells. Perhaps this is because of the differences in the structure of the *Tetrahymena* proteins compared with their mammalian counterparts. Recognizing the potential pitfalls of relying solely upon pharmacological data, we supplemented behavioral assays with other kinds of tests, such as Western blots, immunofluorescence, and EIA when available. In all cases, the additional tests confirmed the data we originally obtained using pharmacological inhibitors.

Taken together, our data indicate that a number of enzymes are involved in GTP signaling. However, further experimentation is needed to discern the interrelationships between enzymes in the pathway and to answer the myriad questions that remain. For example, are guanylyl cyclase and NOS truly activated by calcium in *Tetrahymena*? Would calcium chelation abolish their activity? Is there a soluble guanylyl cyclase in *Tetrahymena*? What NOS isoforms do *Tetrahymena* possess? Is tyrosine phosphorylation required for either NOS or guanylyl cyclase activity? Are any additional proteins, particularly ciliary proteins, involved in GTP signaling? Are all of the components of the pathway located in the cilia? These and many other questions remain to be answered. One question we have begun to answer is whether intracellular calcium is required for tyrosine kinase activity. Recent immunofluorescence shows no difference in phosphotyrosine levels between GTP-treated cells and GTP-treated cells that had been pretreated with BAPTA-AM (unpublished data). Similarly, calcineurin (PP2B) does not appear to be involved in GTP signaling, as ascomycin treatment had no effect on GTP avoidance (unpublished data). Endothall, a PP2A inhibitor, did inhibit avoidance (unpublished observation), consistent with observations by Deckman and Pennock \[[@CR32]\] that PP2A is involved in ciliary reversal. Further experimentation will help us determine the interrelationship of pathway components and better establish the mechanism by which chemorepellents signal in *Tetrahymena*.

We would like to thank Matthew Tabbut for his help putting the immunofluorescence images together. We would like to thank Dara Fraley for her help scanning our Western blot.

EIA

:   Enzyme immunosorbent assay

cGMP

:   Guanosine 3′3;5′monophosphate

GDP-β-S

:   Guanosine-5′-O- (2-thio)diphosphate

GTP-γ-S

:   Guanosine-5′-O-(3-thio)triphosphate

PKC

:   Protein kinase C

NO

:   Nitric oxide

NOS

:   Nitric oxide synthase

Rp-8-Br-cGMPs

:   Rp-8-Bromoguanosine-3′,5′-cyclic monophosphorothioate

TNP-GTP

:   2′-(or 3′)-*O*-(2,4,6-trinitrophenyl)guanosine 5′-triphosphate
